Hong Kong Healthtech Stock News

Kingsoft (SEHK:3888) is back in focus after reporting its second quarter and first half 2026 results on 19 August, with both revenue and net income higher than the same periods a year earlier. See our latest analysis for Kingsoft. Despite the recent earnings report sparking a 1 day share price return of 2.16% to HK$24.56, Kingsoft’s share price return is still down 15.83% year to date and its 1 year total shareholder return is down 29.19%. This suggests momentum has been weak overall despite...

Sales update and why it matters for Q Technology (Group) stock Q Technology (Group) (SEHK:1478) has released unaudited sales figures for July 2026, giving you a fresh look at shipment volumes across its camera modules, LiDAR units, and biological recognition modules. For July, the company reported total sales volume of 38,493,000 camera modules and LiDAR units, alongside 10,735,000 biological recognition modules. These operational numbers help investors gauge activity levels across Q...

Why VSTECS Holdings Stock Is Back on Investor Radars After Its Half Year Earnings VSTECS Holdings (SEHK:856) is attracting fresh attention after reporting half year 2026 earnings, with sales of HK$52,610.46 million and net income of HK$914.91 million compared to the prior year period. See our latest analysis for VSTECS Holdings. At a latest share price of HK$9.62, VSTECS Holdings has seen a 1 day share price return of 2.61% and a year to date share price return of 18.91%, while the 1 year...

Long term bond buybacks, a softer US dollar and a sharp swing in crypto sentiment have pushed scarce assets such as bitcoin back into the spotlight, along with the stocks tied to that momentum. This shift can reward investors who identify which listed crypto financial infrastructure and trading platforms are most exposed to the news event. This article walks through three such stocks and what their exposure could mean for your portfolio. The stocks covered below are just a sample, and the...

China Hongqiao Group stock came into the H1 2026 release looking cheap on traditional metrics, with a trailing P/E well below Hong Kong metals and mining peers and a discounted value on a discounted cash flow comparison. The earnings headline is all about profitability. Net income from continuing operations over the past twelve months reached ¥29,712.981m with a net margin of 16.3%. That combination of a stronger margin profile and a low earnings multiple is now colliding with investor...

WuXi XDC Cayman (SEHK:2268) has reached a new phase in its international build out with its BCM3 dual function production line in Singapore receiving GMP release and moving into global commercial manufacturing. See our latest analysis for WuXi XDC Cayman. Against this backdrop, WuXi XDC Cayman's momentum has been strong, with a 30 day share price return of 28.75% and a year to date share price return of 16.79%. This has contributed to a 1 year total shareholder return of 24.18% at a latest...

Kuaishou Technology (SEHK:1024) reported second quarter 2026 results on 19 August, with sales at CNY 35,535 million and net income at CNY 3,146 million, reflecting higher revenue alongside reduced profitability. See our latest analysis for Kuaishou Technology. Kuaishou Technology’s latest earnings on 19 August, which showed higher sales alongside lower net income, appear to have weighed on sentiment. The stock’s 1-month share price return is down 20.10% and the year to date share price return...

MMG (SEHK:1208) drew fresh attention after reporting half year 2026 sales of US$4,540.1 million and net income of US$897.2 million, while keeping full year copper and zinc production guidance unchanged. See our latest analysis for MMG. MMG's latest earnings release coincides with a sharp pick up in recent momentum, with the stock posting a 10.81% 7 day share price return and a 93.87% 1 year total shareholder return from a HK$9.325 share price today. This suggests that investors are...

Earnings trigger for Blue Moon Group Holdings stock Blue Moon Group Holdings (SEHK:6993) recently reported half year 2026 results that combined weaker sales with a smaller net loss. This earnings update is an important reference point for how the stock is viewed. See our latest analysis for Blue Moon Group Holdings. The latest half year results appear to have supported improving sentiment around Blue Moon Group Holdings, with a 1-day share price return of 2.47% and a year-to-date share price...

JS Global Lifestyle stock closed at HK$1.575 after a solid run in recent weeks, yet the real story sits in the profit line. H1 2026 delivered basic earnings per share of US$0.003 and net income of US$9.419 million, keeping the recent turn back to profitability intact but at a modest level for a global home appliances player. The market is treating JS Global Lifestyle as a recovery and growth story, helped by a trailing P/E of 15.7x. The key question now is whether this earnings quality...

Investors in NetEase, Inc. ( HKG:9999 ) had a good week, as its shares rose 4.3% to close at HK$202 following the...

CSPC Pharmaceutical Group Limited ( HKG:1093 ) defied analyst predictions to release its half-year results, which were...

As you might know, Pop Mart International Group Limited ( HKG:9992 ) last week released its latest interim, and things...

As you might know, 3SBio Inc. ( HKG:1530 ) last week released its latest interim, and things did not turn out so great...

K Cash stock closed at HK$1.78 on the day of its H1 2026 report, after a flat month and a slightly softer 90 day run. The headline is not the share price; it is the earnings power behind it. Basic earnings per share for the half came in at HK$0.1022 and trailing twelve month earnings now support a P/E of 9.4x. For a consumer finance stock with a 39.3% net profit margin and a 6.85% dividend yield, this earnings print highlights a time horizon choice. Traders may focus on near term price...

BioDlink International has been trading like a recovery story, with the stock up about 17% over the past month. However, H1 2026 results underline that this is still a loss making biotech with a valuation built on hope rather than profit. The headline this half is the profit squeeze. Revenue came in at ¥246.011 million, while net income excluding extra items showed a loss of ¥58.517 million and basic earnings per share were also in the red. The share price reaction now rests on how long...

Texwinca Holdings Limited ( HKG:321 ) stock is about to trade ex-dividend in 3 days. The ex-dividend date generally...

Shareholders might have noticed that Stella International Holdings Limited ( HKG:1836 ) filed its half-year result this...

We wouldn't blame Majestic Dragon AeroTech Holdings Limited ( HKG:918 ) shareholders if they were a little worried...

China Telecom Corporation Limited ( HKG:728 ) just released its latest interim report and things are not looking great...

It looks like Convenience Retail Asia Limited ( HKG:831 ) is about to go ex-dividend in the next 3 days. The...

Ten Pao Group Holdings Limited ( HKG:1979 ) shareholders (or potential shareholders) will be happy to see that the...

China Overseas Property Holdings Limited ( HKG:2669 ) just released its interim report and things are looking bullish...

Dingdang Health Technology Group closed at HK$0.78 on the day of its H1 2026 results, with the stock coming off a weak 3 month stretch that left it down about 15%. The headline is not about revenue size for this online pharmacy player. It is about profitability pressure returning, with a reported loss of CNY 64.371 million and basic earnings per share back in the red at CNY 0.05. Short term traders will focus on that setback. Longer term investors will focus on whether the ongoing loss...